These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 32368052

  • 1. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
    Tao R, Wang C, Lu Y, Zhang C, Zhou H, Chen H, Li W.
    Int J Nanomedicine; 2020; 15():2733-2749. PubMed ID: 32368052
    [Abstract] [Full Text] [Related]

  • 2. Poly(lactic-co-glycolic acid)-loaded nanoparticles of betulinic acid for improved treatment of hepatic cancer: characterization, in vitro and in vivo evaluations.
    Kumar P, Singh AK, Raj V, Rai A, Keshari AK, Kumar D, Maity B, Prakash A, Maiti S, Saha S.
    Int J Nanomedicine; 2018; 13():975-990. PubMed ID: 29497292
    [Abstract] [Full Text] [Related]

  • 3. Characterization, Cytotoxicity and Genotoxicity of Graphene Oxide and Folate Coupled Chitosan Nanocomposites Loading Polyprenol and Fullerene Based Nanoemulsion Against MHCC97H Cells.
    Tao R, Wang C, Zhang C, Li W, Zhou H, Chen H, Ye J.
    J Biomed Nanotechnol; 2019 Mar 01; 15(3):555-570. PubMed ID: 31165700
    [Abstract] [Full Text] [Related]

  • 4. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A, Kumar R, Singh A, Dhar Dubey R, Mintoo MJ, Singh G, Mondhe DM, Panda AK, Gupta PN.
    Int J Pharm; 2017 Oct 05; 531(1):153-166. PubMed ID: 28823888
    [Abstract] [Full Text] [Related]

  • 5. Betulinic acid induces apoptosis and suppresses metastasis in hepatocellular carcinoma cell lines in vitro and in vivo.
    Wang W, Wang Y, Liu M, Zhang Y, Yang T, Li D, Huang Y, Li Q, Bai G, Shi L.
    J Cell Mol Med; 2019 Jan 05; 23(1):586-595. PubMed ID: 30417527
    [Abstract] [Full Text] [Related]

  • 6. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y, Hu L, Huang S, Xu W, Wan J, Wang D, Zheng G, Xia Z.
    Int J Nanomedicine; 2018 Jan 05; 13():8309-8323. PubMed ID: 30584302
    [Abstract] [Full Text] [Related]

  • 7. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Zhu D, Tao W, Zhang H, Liu G, Wang T, Zhang L, Zeng X, Mei L.
    Acta Biomater; 2016 Jan 05; 30():144-154. PubMed ID: 26602819
    [Abstract] [Full Text] [Related]

  • 8. Folic acid modified TPGS as a novel nano-micelle for delivery of nitidine chloride to improve apoptosis induction in Huh7 human hepatocellular carcinoma.
    Li D, Liu S, Zhu J, Shen L, Zhang QY, Zhu H.
    BMC Pharmacol Toxicol; 2021 Jan 06; 22(1):1. PubMed ID: 33407916
    [Abstract] [Full Text] [Related]

  • 9. Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma.
    Li Y, Wang Y, Gao L, Tan Y, Cai J, Ye Z, Chen AT, Xu Y, Zhao L, Tong S, Sun Q, Liu B, Zhang S, Tian D, Deng G, Zhou J, Chen Q.
    J Nanobiotechnology; 2022 Jan 21; 20(1):39. PubMed ID: 35062946
    [Abstract] [Full Text] [Related]

  • 10. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.
    Wang J, Liu W, Tu Q, Wang J, Song N, Zhang Y, Nie N, Wang J.
    Biomacromolecules; 2011 Jan 10; 12(1):228-34. PubMed ID: 21158381
    [Abstract] [Full Text] [Related]

  • 11. Sorafenib-Loaded Nanoparticles Based on Biodegradable Dendritic Polymers for Enhanced Therapy of Hepatocellular Carcinoma.
    Li Z, Ye L, Liu J, Lian D, Li X.
    Int J Nanomedicine; 2020 Jan 10; 15():1469-1480. PubMed ID: 32184599
    [Abstract] [Full Text] [Related]

  • 12. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
    Bao X, Gao M, Xu H, Liu KX, Zhang CH, Jiang N, Chu QC, Guan X, Tian Y.
    Drug Dev Ind Pharm; 2015 Jan 10; 41(7):1193-203. PubMed ID: 25026246
    [Abstract] [Full Text] [Related]

  • 13. Chitosan-g-TPGS nanoparticles for anticancer drug delivery and overcoming multidrug resistance.
    Guo Y, Chu M, Tan S, Zhao S, Liu H, Otieno BO, Yang X, Xu C, Zhang Z.
    Mol Pharm; 2014 Jan 06; 11(1):59-70. PubMed ID: 24229050
    [Abstract] [Full Text] [Related]

  • 14. Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles.
    Sahin A, Spiroux F, Guedon I, Arslan FB, Sarcan ET, Ozkan T, Colak N, Yuksel S, Ozdemir S, Ozdemir B, Akbas S, Ultav G, Aktas Y, Capan Y.
    Pharmazie; 2017 Sep 01; 72(9):525-528. PubMed ID: 29441979
    [Abstract] [Full Text] [Related]

  • 15. Formulation, Characterization And Evaluation Of Curcumin- Loaded PLGA- TPGS Nanoparticles For Liver Cancer Treatment.
    Chen XP, Li Y, Zhang Y, Li GW.
    Drug Des Devel Ther; 2019 Sep 01; 13():3569-3578. PubMed ID: 31802845
    [Abstract] [Full Text] [Related]

  • 16. Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy.
    Wu JY, Wang ZX, Zhang G, Lu X, Qiang GH, Hu W, Ji AL, Wu JH, Jiang CP.
    Int J Nanomedicine; 2018 Sep 01; 13():1265-1280. PubMed ID: 29551896
    [Abstract] [Full Text] [Related]

  • 17. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW, Zhao P, Khan A, Raza F, Raza SM, Sarfraz M, Chen Y, Li M, Yang T, Ma X, Xiang G.
    Int J Nanomedicine; 2019 Sep 01; 14():3753-3771. PubMed ID: 31239661
    [Abstract] [Full Text] [Related]

  • 18. Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver Cancer.
    Liu H, Xu H, Zhang C, Gao M, Gao X, Ma C, Lv L, Gao D, Deng S, Wang C, Tian Y.
    Pharm Res; 2016 Nov 01; 33(11):2828-43. PubMed ID: 27511028
    [Abstract] [Full Text] [Related]

  • 19. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS, Mei L, Anitha P, Gan CW, Zhou W.
    Biomaterials; 2009 Jul 01; 30(19):3297-306. PubMed ID: 19299012
    [Abstract] [Full Text] [Related]

  • 20. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H, Wu M, Zhu L, Tian Y, Wu M, Li Y, Deng L, Jiang W, Shen W, Wang Z, Mei Z, Li P, Ran H, Zhou Z, Ren J.
    Theranostics; 2018 Jul 01; 8(7):1892-1910. PubMed ID: 29556363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.